News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171 Results
Type
Article (2)
Press Release (169)
Section
Business (61)
Deals (11)
Drug Development (9)
FDA (1)
News (78)
Policy (3)
Tag
Alliances (21)
Approvals (1)
Artificial intelligence (2)
Cancer (1)
Clinical research (2)
Collaboration (1)
COVID-19 (2)
Diabetes (1)
Diagnostics (1)
Drug discovery (2)
Earnings (34)
Events (30)
Executive appointments (1)
FDA (2)
Funding (1)
GLP-1 (2)
Government (1)
Healthcare (16)
Infectious disease (2)
IPO (9)
Machine learning (1)
Mergers & acquisitions (4)
Metabolic disorders (1)
People (14)
Phase 1 (2)
Phase 2 (2)
Phase 3 (1)
Preclinical (8)
Regulatory (2)
Vaccines (2)
Date
Last 365 days (18)
2025 (21)
2024 (20)
2023 (24)
2022 (27)
2021 (34)
2020 (34)
2019 (3)
2018 (4)
2017 (4)
Location
Asia (2)
Canada (17)
China (1)
Europe (6)
Texas (20)
United States (21)
Utah (1)
171 Results for "immunoprecise".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 15, 2025
·
4 min read
Press Releases
ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation
August 28, 2025
·
4 min read
Press Releases
ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery
June 5, 2025
·
7 min read
Press Releases
ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts
May 21, 2025
·
2 min read
Business
ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer
ImmunoPrecise Antibodies Ltd. is pleased to announce the appointment of Kristin Taylor as Chief Financial Officer, effective immediately.
June 27, 2024
·
3 min read
Press Releases
ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference
May 20, 2025
·
2 min read
Press Releases
ImmunoPrecise Antibodies Announces Key Leadership Changes
February 24, 2025
·
6 min read
Press Releases
AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies
June 12, 2025
·
5 min read
Press Releases
ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology
June 24, 2025
·
8 min read
Press Releases
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA’s Shift to Non-Animal Testing Methods
April 11, 2025
·
4 min read
1 of 18
Next
